Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piyush Patel

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Molecular Medicine (Cambridge, Mass.)|April 10, 2026
TNFα signaling in radiation-induced chronic bowel dysfunction suggests therapeutic potential for IBD biologicsSravani Devarakonda, Piyush Patel, Amelie Toft Morén, et al.
Nature Medicine|April 27, 2005
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer diseaseMark H Tuszynski, Leon Thal, Mary Pay, et al.
Breast (Edinburgh, Scotland)|October 8, 2021
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter studySudeep Gupta, Ghanashyam Biswas, Suresh Babu, et al.
Journal of Diabetes|April 14, 2026
Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active-Controlled StudyBrij Mohan, S Vasanth Kumar, Prakash Harishchandra Kurmi, et al.
Diabetes, Obesity & Metabolism|February 14, 2025
Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in IndiaRakesh Sahay, Dinesh Gangwani, Manish Singh, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2020
Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergenDavid Larson, Piyush Patel, Anne Marie Salapatek, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 12, 2026
Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate-to-Severe Endometriosis Pain: A Phase III, Multicentric, Double-Blind, Active-Controlled, Non-Inferiority StudySneha Bhoir, Jaldhara Patel, Tushar Palve, et al.
Diabetes, Obesity & Metabolism|May 3, 2026
Sitagliptin, Metformin and Glimepiride Fixed-Dose Combination Compared to Co-Administration of Metformin and High-Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double-Blind, Double-Dummy, Phase 3 Clinical StudyRakesh Sahay, Ambanna Gowda, Manish Kumar Singh, et al.
Bipolar Disorders|December 28, 2020
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorderAteeq Ahmad, Saifuddin Sheikh, Mujtaba Ali Khan, et al.
Bipolar Disorders|November 13, 2021
Reply to Ghosh et al<sup>1</sup> . Comments on Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorderAteeq Ahmad, Saifuddin Sheikh, Mujtaba Ali Khan, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Molecular Medicine (Cambridge, Mass.)|April 10, 2026
TNFα signaling in radiation-induced chronic bowel dysfunction suggests therapeutic potential for IBD biologicsSravani Devarakonda, Piyush Patel, Amelie Toft Morén, et al.
Nature Medicine|April 27, 2005
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer diseaseMark H Tuszynski, Leon Thal, Mary Pay, et al.
Breast (Edinburgh, Scotland)|October 8, 2021
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter studySudeep Gupta, Ghanashyam Biswas, Suresh Babu, et al.
Journal of Diabetes|April 14, 2026
Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active-Controlled StudyBrij Mohan, S Vasanth Kumar, Prakash Harishchandra Kurmi, et al.
Diabetes, Obesity & Metabolism|February 14, 2025
Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in IndiaRakesh Sahay, Dinesh Gangwani, Manish Singh, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2020
Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergenDavid Larson, Piyush Patel, Anne Marie Salapatek, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 12, 2026
Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate-to-Severe Endometriosis Pain: A Phase III, Multicentric, Double-Blind, Active-Controlled, Non-Inferiority StudySneha Bhoir, Jaldhara Patel, Tushar Palve, et al.
Diabetes, Obesity & Metabolism|May 3, 2026
Sitagliptin, Metformin and Glimepiride Fixed-Dose Combination Compared to Co-Administration of Metformin and High-Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double-Blind, Double-Dummy, Phase 3 Clinical StudyRakesh Sahay, Ambanna Gowda, Manish Kumar Singh, et al.
Bipolar Disorders|December 28, 2020
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorderAteeq Ahmad, Saifuddin Sheikh, Mujtaba Ali Khan, et al.
Bipolar Disorders|November 13, 2021
Reply to Ghosh et al<sup>1</sup> . Comments on Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorderAteeq Ahmad, Saifuddin Sheikh, Mujtaba Ali Khan, et al.
Pageof 8